Otipax (Phenazone, Lidocaine Hydrochloride)

Phenazone, the active ingredient in Otipax, is an analgesic and local anesthetic presented as a topical formulation for ear canal use. It relieves pain and discomfort associated with otic conditions. GNH USA supplies Otipax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otipax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otipax combines phenazone and lidocaine to address ear‑related pain pathways. It is indicated for: - Otitis externa: reduces pain and discomfort during inflammation. - Ear canal irritation after swimming or water exposure : alleviates burn and tingling sensation. - Minor trauma to the external ear : eases pain and facilitates healing. - Post‑procedural ear care after auricular clean‑up : provides local analgesia. - Chronic ear dry skin : moistur soothing effect and symptom relief.

Otipax may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Mild burning sensation at the application site. - Transient itching or redness. - Slight ear fullness. - Temporary taste alteration. - Minor dizziness. - Localized swelling.

Serious or Rare Side Effects: - Allergic dermatitis or severe skin reaction. - Persistent otitis media. - Significant hearing loss. - Systemic toxicity from lidocaine absorption. - Anaphylaxis. - Unexplained severe vertigo.

Before using Otipax, consider the following safety measures: - Allergy assessment: verify the presence of any known phenazone or lidocaine hypersensitivity. - Ear condition review: ensure the ear is intact and free of perforation. - Pediatric use: limit use in children under the recommended age by the prescriber. - Concomitant otic medications: avoid simultaneous use with other ototoxic preparations. - Pregnancy & lactation: use only if clearly indicated by the healthcare professional. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Otipax can interact with other medicines applied to the ear or systemically absorbed agents.

Major Interactions (Avoid): - Concurrent use of other topical anesthetics: may increase local lidocaine exposure. - Ototoxic antibiotics (e.g., aminoglycosides): heightened risk of ear toxicity.

Moderate Interactions (Monitor Closely): - Systemic lidocaine therapy: additive sodium‑channel blockade. - CYP enzyme modulators that affect phenazone metabolism. - Anticoagulants: potential for altered bleeding if ear trauma occurs. - Alcohol consumption: may enhance systemic absorption of phenazone. - Herbal supplements such as ginkgo biloba that affect platelet function.